BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34207594)

  • 1. Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making.
    Mandel P; Wenzel M; Hoeh B; Welte MN; Preisser F; Inam T; Wittler C; Humke C; Köllermann J; Wild P; Würnschimmel C; Tilki D; Graefen M; Kluth LA; Karakiewicz PI; Chun FK; Becker A
    Curr Oncol; 2021 Jun; 28(3):2123-2133. PubMed ID: 34207594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
    He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
    Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance.
    Bokhorst LP; Roobol MJ; Bangma CH; van Leenders GJ
    Prostate; 2017 Jul; 77(10):1137-1143. PubMed ID: 28543353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.
    Leone A; Gershman B; Rotker K; Butler C; Fantasia J; Miller A; Afiadata A; Amin A; Zhou A; Jiang Z; Sebo T; Mega A; Schiff S; Pareek G; Golijanin D; Yates J; Karnes RJ; Renzulli J
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):68-71. PubMed ID: 26857145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
    Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
    J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.
    Guazzoni G; Lazzeri M; Nava L; Lughezzani G; Larcher A; Scattoni V; Gadda GM; Bini V; Cestari A; Buffi NM; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):455-66. PubMed ID: 22078333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
    Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB
    Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Morash C; Bateman J; Mai KT; Belanger EC; Robertson SJ; Breau RH
    Pathol Int; 2016 Nov; 66(11):629-632. PubMed ID: 27709739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
    Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of reporting discontinuous tumor involvement in prostatic needle biopsy: a systematic review.
    Lu M; Wu S; Wu CL
    Virchows Arch; 2021 Mar; 478(3):383-391. PubMed ID: 33404850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
    Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy.
    Zhang J; Xiu J; Dong Y; Wang M; Han X; Qin Y; Huang Z; Cai S; Yuan X; Liu Q
    Mol Med Rep; 2014 May; 9(5):1989-97. PubMed ID: 24584266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?
    Dorin RP; Wiener S; Harris CD; Wagner JR
    Prostate; 2015 May; 75(7):673-8. PubMed ID: 25597982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer.
    Kim KH; Kim YB; Lee JK; Kim YJ; Jung TY
    Korean J Urol; 2010 Jun; 51(6):398-402. PubMed ID: 20577606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
    Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
    Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy.
    Boehm K; Tennstedt P; Beyer B; Schiffmann J; Beckmann A; Michl U; Beyersdorff D; Budäus L; Graefen M; Karakiewicz PI; Salomon G
    World J Urol; 2016 Jun; 34(6):805-10. PubMed ID: 26481227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.